Literature DB >> 11327178

Conducting research on the Medicare market: the need for better data and methods.

H S Wong1, F J Hellinger.   

Abstract

OBJECTIVE: To highlight data limitations, the need to improve data collection, the need to develop better analytic methods, and the need to use alternative data sources to conduct research related to the Medicare program. Objectives were achieved by reviewing existing studies on risk selection in Medicare HMOs, examining their data limitations, and introducing a new approach that circumvents many of these shortcomings. DATA SOURCES: Data for years 1995-97 for five states (Arizona, Florida, Massachusetts, New York, and Pennsylvania) from the Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SIDs), maintained by the Agency for Healthcare Research and Quality; and the Health Care Financing Administration's Medicare Managed Care Market Penetration Data Files and Medicare Provider Analysis and Review Files. STUDY
DESIGN: Analysis of hospital utilization rates for Medicare beneficiaries in the traditional fee-for-service (FFS) Medicare and Medicare HMO sectors and examination of the relationship between these rates and the Medicare HMO penetration rates. PRINCIPAL
FINDINGS: Medicare HMOs have lower hospital utilization rates than their FFS counterparts, differences in utilization rates vary across states, and HMO penetration rates are inversely related to our rough measure of favorable selection.
CONCLUSIONS: Substantial growth in Medicare HMO enrollment and the implementation of a new risk-adjusted payment system have led to an increasing need for research on the Medicare program. Improved data collection, better methods, new creative approaches, and alternative data sources are needed to address these issues in a timely and suitable manner.

Mesh:

Year:  2001        PMID: 11327178      PMCID: PMC1089206     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  15 in total

1.  Medicare reform: fundamental problems, incremental steps.

Authors:  M McClellan
Journal:  J Econ Perspect       Date:  2000

2.  Biased selection and Medicare HMOs: analysis of the 1989-1994 experience.

Authors:  D F Cox; C Hogan
Journal:  Med Care Res Rev       Date:  1997-09       Impact factor: 3.929

3.  Does managed care lead to better or worse quality of care?

Authors:  R H Miller; H S Luft
Journal:  Health Aff (Millwood)       Date:  1997 Sep-Oct       Impact factor: 6.301

4.  Do health maintenance organizations work for Medicare?

Authors:  R S Brown; D G Clement; J W Hill; S M Retchin; J W Bergeron
Journal:  Health Care Financ Rev       Date:  1993

5.  Selection experiences in Medicare HMOs: pre-enrollment expenditures.

Authors:  K T Call; B Dowd; R Feldman; M Maciejewski
Journal:  Health Care Financ Rev       Date:  1999

6.  Pre-enrollment reimbursement patterns of Medicare beneficiaries enrolled in "at-risk" HMOs.

Authors:  P W Eggers; R Prihoda
Journal:  Health Care Financ Rev       Date:  1982-09

7.  Selection bias in health maintenance organizations: analysis of recent evidence.

Authors:  F J Hellinger
Journal:  Health Care Financ Rev       Date:  1987

8.  Risk differential between Medicare beneficiaries enrolled and not enrolled in an HMO.

Authors:  P Eggers
Journal:  Health Care Financ Rev       Date:  1980

9.  Adjusting Medicare capitation payments using prior hospitalization data.

Authors:  A Ash; F Porell; L Gruenberg; E Sawitz; A Beiser
Journal:  Health Care Financ Rev       Date:  1989
View more
  2 in total

1.  Injuries among older Americans with and without Medicare.

Authors:  David E Clark; Michael A DeLorenzo; F L Lucas; David E Wennberg
Journal:  Am J Public Health       Date:  2005-02       Impact factor: 9.308

2.  Measuring access to effective care among elderly medicare enrollees in managed and Fee-for-Service care: a retrospective cohort study.

Authors:  M B Barton; D A Dayhoff; S B Soumerai; M L Rosenbach; R H Fletcher
Journal:  BMC Health Serv Res       Date:  2001-11-01       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.